NovoCure Ltd (FRA:038)
€ 16.225 -0.425 (-2.55%) Market Cap: 1.75 Bil Enterprise Value: 1.48 Bil PE Ratio: 0 PB Ratio: 5.23 GF Score: 69/100

Novocure Ltd Virtual Research & Development Day Transcript

Nov 12, 2020 / 12:30PM GMT
Release Date Price: €106.9 (+6.99%)
Operator

Good morning, everyone, and thank you for joining us to take part in NovoCure's 2020 Virtual Research and Development Day.

In addition to today's prepared remarks, there will be 2 live question-and-answer session, facilitated by Dr. Piet Hinoul, NovoCure's Senior Vice President of Global Medical Affairs. (Operator Instructions)

Today's presentation and a live webcast will be available on the Investor Relations page of our website. www.novocure.com, and will be available for replay for at least 14 days following the event.

Before we start, I would like to remind you that our discussions during this event will include forward-looking statements, and actual results could differ materially from those projected in these statements. These statements involve a number of risks and uncertainties, some of which are beyond our control, including those risks and uncertainties described from time to time in our SEC filings. We do not intend to update publicly any forward-looking statement, except as required by law.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot